InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,248.18
(
0.25%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

quantumdot

Send PM Follow Ignore
Followers 6
Posts 671
Boards Moderated 0
Alias Born 07/19/2006

quantumdot

Re: DewDiligence post# 64540

Wednesday, 07/23/2008 12:11:39 PM

Wednesday, July 23, 2008 12:11:39 PM

Post# of 252302
Biotech buyouts. Does Roche's pretty aggressive $3.4 billion swallowing of Ventana qualify for your table? It was finally consummated in Feb 2008 and represented a hefty 73% premium to the share price prior to their first hostile offer last year.

http://www.labtechnologist.com/news/ng.asp?n=82685-roche-ventana-companion-diagnostics-breast-cancer-personalised-medicine
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up